Manik L. Debnath

10.0k citations

40 papers · 4.2k indexed · 3 hit papers · h-index 19

Physiology top 0.5%
Psychiatry and Mental health top 0.5%
Molecular Biology top 10%
Radiology, Nuclear Medicine and Imaging top 2%
Cognitive Neuroscience top 5%

Co-authors: William E. Klunk Chester A. Mathis Guo-Feng Huang Daniel P. Holt Yanming Wang Miloš D. Ikonomović Steven T. DeKosky Bradley T. Hyman
Topics: Alzheimer's disease research and treatments (27 papers)Computational Drug Discovery Methods (11 papers)Cholinesterase and Neurodegenerative Diseases (8 papers)
Cited by: Physiology Psychiatry and Mental health Neurology
Journals: Journal of Neuroscience NeuroImage Brain
Partner nations: United States Japan Spain

In The Last Decade

Manik L. Debnath

40 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthesis and Evaluation of ¹¹C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents

2003 828 citations Chester A. Mathis, Yanming Wang et al. Journal of Medicinal Chemistry profile →
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

2008 681 citations Miloš D. Ikonomović, William E. Klunk et al. profile →
Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue

2015 450 citations Marta Marquié, Marc D. Normandin et al. Annals of Neurology profile →

Peers

Countries citing papers authored by Manik L. Debnath

Since Specialization

Citations

This map shows the geographic impact of Manik L. Debnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manik L. Debnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manik L. Debnath more than expected).

Fields of papers citing papers by Manik L. Debnath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manik L. Debnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manik L. Debnath. The network helps show where Manik L. Debnath may publish in the future.

Co-authorship network of co-authors of Manik L. Debnath

This figure shows the co-authorship network connecting the top 25 collaborators of Manik L. Debnath. A scholar is included among the top collaborators of Manik L. Debnath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manik L. Debnath. Manik L. Debnath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography Radiotracers 2025 ·Journal of Medicinal Chemistry ·Jeffrey S. Stehouwer,Guofeng Huang,(unknown),Manik L. Debnath,(unknown),Steven J. Geib,Brian J. Lopresti,Miloš D. Ikonomović,N. Scott Mason,Robert H. Mach,Chester A. Mathis	1
2	Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissuebreakdown → 2015 ·Annals of Neurology ·Marta Marquié,Marc D. Normandin,Charles Vanderburg,Isabel Costantino,Elizabeth Bien,(unknown),William E. Klunk,Chester A. Mathis,Miloš D. Ikonomović,Manik L. Debnath,Neil Vasdev,Bradford C. Dickerson,Stephen N. Gomperts,John H. Growdon,Keith A. Johnson,Matthew P. Frosch,Bradley T. Hyman,Teresa Gómez‐Isla	450
3	Design, synthesis and structure–activity relationship of rhenium 2-arylbenzothiazoles as β-amyloid plaque binding agents 2013 ·Bioorganic & Medicinal Chemistry Letters ·Jinhe Pan,N. Scott Mason,Manik L. Debnath,Chester A. Mathis,William E. Klunk,Kuo‐Shyan Lin	15
4	Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study 2012 ·Acta Neuropathologica ·Miloš D. Ikonomović,Eric E. Abrahamson,Julie C. Price,Ronald L. Hamilton,Chester A. Mathis,William R. Paljug,Manik L. Debnath,(unknown),Katsuyoshi Mizukami,Steven T. DeKosky,Oscar L. López,William E. Klunk	68
5	Synthesis and β-amyloid binding properties of rhenium 2-phenylbenzothiazoles 2009 ·Bioorganic & Medicinal Chemistry Letters ·Kuo‐Shyan Lin,Manik L. Debnath,Chester A. Mathis,William E. Klunk	31
6	X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease 2006 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Miloš D. Ikonomović,Eric E. Abrahamson,Barbara A. Isanski,Manik L. Debnath,Chester A. Mathis,Steven T. DeKosky,William E. Klunk	45
7	An Aβ Sequestration Approach Using Non-Antibody Aβ Binding Agents 2005 ·Current Alzheimer Research ·Yasuji Matsuoka,Shao Li,Manik L. Debnath,John J. LaFrancois,(unknown),Audrey Gray,Paul Aisen,Chester A. Mathis,William E. Klunk,Karen Duff	7
8	Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain 2005 ·Journal of Neuroscience ·William E. Klunk,Brian J. Lopresti,Miloš D. Ikonomović,Iliya Lefterov,Radosveta Koldamova,Eric E. Abrahamson,Manik L. Debnath,Daniel P. Holt,Guo-Feng Huang,Shao Li,Steven T. DeKosky,Julie C. Price,Chester A. Mathis	294
9	Development of a PET/SPECT Agent for Amyloid Imaging in Alzheimer's Disease 2004 ·Journal of Molecular Neuroscience ·Yanming Wang,William E. Klunk,Manik L. Debnath,Guo-Feng Huang,Daniel P. Holt,Shao Li,Chester A. Mathis	63
10	Synthesis and evaluation of 2-(3′-lodo-4′-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in alzheimer’s disease 2002 ·Journal of Molecular Neuroscience ·Yanming Wang,William E. Klunk,Guo-Feng Huang,Manik L. Debnath,Daniel P. Holt,Chester A. Mathis	42
11	Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy-X04, a Systemically Administered Congo Red Derivative 2002 ·Journal of Neuropathology & Experimental Neurology ·William E. Klunk,Brian J. Bacskai,Chester A. Mathis,Stephen T. Kajdasz,Megan E. McLellan,Matthew P. Frosch,Manik L. Debnath,Daniel P. Holt,Yanming Wang,Bradley T. Hyman	320
12	A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain 2002 ·Bioorganic & Medicinal Chemistry Letters ·Chester A. Mathis,Brian J. Bacskai,Stephen T. Kajdasz,Megan E. McLellan,Matthew P. Frosch,Bradley T. Hyman,Daniel P. Holt,Yanming Wang,Guo-Feng Huang,Manik L. Debnath,William E. Klunk	282
13	Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain 2001 ·Life Sciences ·William E. Klunk,(unknown),Guo-Feng Huang,Manik L. Debnath,(unknown),Chester A. Mathis	377
14	Lipophilic ¹¹C‐labelled thioflavin‐T analogues for imaging amyloid plaques in alzheimer's disease 2001 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Chester A. Mathis,Daniel P. Holt,Yadong Wang,(unknown),Manik L. Debnath,William E. Klunk	13
15	Chrysamine-G, a lipophilic analogue of congo red, inhibits Aβ-induced toxicity in PC12 cells 1998 ·Life Sciences ·William E. Klunk,Manik L. Debnath,Aurelia M. C. Koros,Jay W. Pettegrew	72
16	Synthesis and Cytotoxic Action of 3,5‐Isoxazolidinediones and 2‐Isoxazolin‐5‐ones in Murine and Human Tumors 1997 ·Archiv der Pharmazie ·Iris H. Hall,Robert A. Izydore,(unknown),(unknown),(unknown),Manik L. Debnath,(unknown),(unknown)	9
17	Investigation of 3,5-Isoxazolidinediones as Hypolipidemic Agents in Rodents 1995 ·Pharmaceutical Research ·(unknown),Manik L. Debnath,(unknown),Robert A. Izydore,(unknown),Oi T. Wong,(unknown),(unknown)	9
18	Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease 1994 ·Neurobiology of Aging ·William E. Klunk,Manik L. Debnath,Jay W. Pettegrew	146
19	Small molecule beta-amyloid probes which distinguish homogenates of Alzheimer's and control brains 1994 ·Biological Psychiatry ·William E. Klunk,Manik L. Debnath,Jay W. Pettegrew	14
20	The antineoplastic and cytotoxicity of benzohydroxamic acids and related derivatives in murine and human tumor cells 1992 ·Anti-Cancer Drugs ·(unknown),Robert A. Izydore,(unknown),(unknown),(unknown),Manik L. Debnath,(unknown)	4

About Manik L. Debnath

Manik L. Debnath is a scholar working on Physiology, Computational Theory and Mathematics and Biochemistry, having authored 40 papers that have together received 4.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (27 papers), Computational Drug Discovery Methods (11 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). The work is most often cited by research in Physiology (3.1k citations), Psychiatry and Mental health (1.4k citations) and Neurology (495 citations). Manik L. Debnath has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include William E. Klunk, Chester A. Mathis, Guo-Feng Huang, Daniel P. Holt, Yanming Wang, Miloš D. Ikonomović, Steven T. DeKosky, Bradley T. Hyman, Matthew P. Frosch and Eric E. Abrahamson. Their work appears in journals such as Journal of Neuroscience, NeuroImage and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact